ORIGINAL RESEARCH

Contrast enhanced MRI of tumors using gadopentetic acid linked to cyclodextrin by an ester bond

Kulakov VN1, Lipengolts AA1,2, Grigorieva EYu2, Semeikin AV3, Abakumov MA3, Karakhanov EA4, Maximov AB4, Shimanovsky NL3
About authors

1 Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency, Moscow, Russia

2 N. N. Blokhin Russian Cancer Research Center, Moscow, Russia

3 P. V. Sergeev Molecular Pharmacology and Radiobiology Department, Biomedical Faculty,
Pirogov Russian National Research Medical University, Moscow, Russia

4 Department of Petroleum Chemistry and Organic Catalysis, Faculty of Chemistry,
Lomonosov Moscow State University, Moscow, Russia

Correspondence should be addressed: Nikolay Shimanovsky
ul. Ostrovityanova, d. 1, Moscow, Russia, 117997; ur.umsr@namihs

About paper

Funding: this work was supported by Government Contract No. 11411.1008700.13.081 dated September 13, 2011 as part of the Federal Targeted Program for the Development of Pharmaceutical and Medical Industry of the Russian Federation until 2020.

Received: 2016-08-15 Accepted: 2016-08-25 Published online: 2017-01-05
|
  1. Buylov VM. Magnetic resonance contrast agents and nephrogenic fibrosing dermatosis and systemic fibrosis (review article). Medical Visualization. 2007; (2): 140–3. Russian.
  2. Szejtli J. Cyclodextrin technology. Dordrecht, Netherlands: Kluwer Academic Publishers; 1988. 450 p.
  3. Dodziuk H, editor. Cyclodextrins and their complexes: Chemistry, analytical methods, applications. Weinheim, Germany: Wiley-VCH; 2006. 489 p.
  4. Ogoshi T, Harada A. Chemical Sensors Based on Cyclodextrin Derivatives. Sensors. 2008; 8: 4961–82.
  5. Battistini E, Gianolio E, Gref R, Couvreur P, Fuzerova S, Othman M, et al. High-relaxivity magnetic resonance imaging (MRI) contrast agent based on supramolecular assembly between a gadolinium chelate, a modified dextran, and poly-beta-cyclodextrin. Chemistry. 2008; 14 (15): 4551–61.
  6. Bryson JM, Chu WJ, Lee JH, Reineke TM. A β-cyclodextrin “click cluster” decorated with seven paramagnetic chelates containing two water exchange sites. Bioconjug Chem. 2008 Aug; 19 (8): 1505–9.
  7. Kulakov VN, Lipengol'ts AA, Karakhanov EA, Maksimov AL, Grigor'eva EYu, Cherepanov АА, inventors. Modifitsirovannye gadopentetatom proizvodnye beta-tsiklodekstrina. Russian Federation patent No. 2541090. 2013 Nov 28. Russian.
  8. Bernistein MA, King KF, Zhou XJ. Handbook of MRI pulse sequences. Burlington, MA: Elsevier Academic Press; 2004. 788 p.
  9. Mironov AN, Bunatyan ND, Vasil'ev AN, Verstakova OL, Zhuravleva MV, Lepakhin VK, et al, editors. Rukovodstvo po provedeniyu doklinicheskikh issledovanii lekarstvennykh sredstv. Moscow: Grif i K; 2012. 944 p. Russian.
  10. Fisenko VP, editor. Rukovodstvo po eksperimental'nomu (doklinicheskomu) izucheniyu novykh farmakologicheskikh veshchestv. Moscow: Remedium; 2000. p. 18–25. Russian.
  11. Evropeiskaya konventsiya po zashchite pozvonochnykh zhivotnykh, ispol'zuemykh dlya eksperimental'nykh i drugikh nauchnykh tselei, EEC, Strasbourg, 1985. Lanimalogiya. 1993; (1): 29. Russian.
  12. Mossman Т. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983 Dec 16; 65 (1–2): 55–63.
  13. Mezhdunarodnye rekomendatsii po provedeniyu mediko-biologicheskikh issledovanii s ispol'zovaniem zhivotnykh. WHO Chron. 1985; 39 (3): 7–9. Russian.